Longevity & Metabolic Health

Advanced glycation end-products (AGEs): how sugar and heat age you

By Hussain Sharifi · 15 min read · Reviewed May 2026

Advanced glycation end-products, or AGEs, are proteins and fats that have been damaged by sugar. The same chemistry that browns toast and sears a steak, the Maillard reaction, happens slowly inside your body whenever blood glucose is high, and faster on a plate of food cooked with dry heat. Over years these sugar-damaged molecules stiffen tissues and stoke low-grade inflammation, which is why they are linked to diabetic complications, ageing skin, and heart and kidney disease. The honest caveat: much of the human evidence is observational, and the diet-focused trials are small, so AGEs are best treated as one real piece of the ageing puzzle rather than the master switch some marketing implies.

On this page
  1. What AGEs actually are
  2. AGEs made inside you: the glucose link
  3. AGEs from food: why cooking method matters
  4. RAGE: how AGEs drive inflammation
  5. The disease links: diabetes, skin, heart, kidney
  6. How good is the evidence, honestly
  7. Can you measure your own AGEs?
  8. What actually lowers your AGE burden
  9. What to ask your GP
  10. What to do next

Key facts

What AGEs actually are

An advanced glycation end-product is what you get when a sugar molecule sticks to a protein, a fat or a strand of DNA without the orderly help of an enzyme, and then that loose attachment matures into something permanent. The process starts gently. A reducing sugar such as glucose latches onto an amino group on a protein to form an early, reversible adduct called a Schiff base, which rearranges into a slightly more stable Amadori product. Glycated haemoglobin, the HbA1c your GP measures, is exactly this kind of early Amadori product on the haemoglobin in your red cells.1

Given enough time, and a series of oxidation and rearrangement steps, some of those early products cross a chemical point of no return and become true AGEs: stable, often cross-linked, and very hard for the body to remove. The same reaction, named after Maillard's 1912 experiments heating sugars with amino acids, is what produces the brown crust and savoury flavour of cooked food.1 In the kitchen it is delicious. In a long-lived protein in your body, it is a slow accumulation of damage.

Two features make AGEs matter biologically. First, they tend to form cross-links between protein strands, tethering molecules that should move freely. Second, many of them are recognised by specific receptors that trigger inflammation. We will come to both. The most-studied individual AGEs have unlovely names you may meet on a lab report: carboxymethyl-lysine (CML), methylglyoxal-derived hydroimidazolone (MG-H1), pentosidine and glucosepane.2

AGEs made inside you: the glucose link

You do not need to eat a single grilled steak to make AGEs. Your body produces them around the clock as a by-product of normal metabolism, and the single biggest driver of how fast is the level of sugar bathing your tissues. The chemistry is dose-dependent: the more glucose in the blood, and the longer it stays high, the more glycation reactions occur. This is the simple reason people with poorly controlled diabetes accumulate AGEs faster than people with normal glucose.2

It is not only glucose. Highly reactive intermediates called dicarbonyls, especially methylglyoxal, are generated as side-products of glucose breakdown, the polyol pathway and lipid peroxidation, and they are far more aggressive glycating agents than glucose itself. The body has defences, notably the glyoxalase enzyme system that mops up methylglyoxal, but when sugar is persistently high these defences are overwhelmed and AGE formation accelerates.2

Which tissues suffer depends partly on how long their proteins live. Proteins that turn over quickly are replaced before much damage sets in. The trouble lands on long-lived proteins: the collagen in skin, tendon and artery walls, the crystallins of the eye lens, the basement membranes of the kidney. These proteins can persist for years or decades, so they act as a running tally of your lifetime glucose exposure. That is why glycation is sometimes described as a biological record of metabolic history, and it connects directly to the early metabolic warning signs we cover in our piece on insulin resistance.

AGEs from food: why cooking method matters

The second source of AGEs is your plate. Because the Maillard reaction is driven by heat, the way you cook a food matters more than the food itself for AGE content. The pivotal reference here is a 2010 paper by Jaime Uribarri and colleagues in the Journal of the American Dietetic Association, which measured the AGE content of 549 foods prepared in different ways. The headline finding: dry, high-temperature cooking such as grilling, frying, broiling and roasting drives AGE formation up by 10 to 100-fold compared with the raw food or the same food cooked wet and low.3

The pattern is consistent. Fatty, protein-rich animal foods cooked with dry heat top the list: a grilled or fried steak, roasted or fried chicken, crisped bacon, full-fat cheese. Carbohydrate-rich foods such as vegetables, fruit, wholegrains and pulses stay low even after cooking. And for any given food, swapping the method matters: boiling, steaming, poaching and stewing keep AGEs low because water caps the temperature near 100C and prevents the browning chemistry, while a hot dry pan or oven runs well above that.3

How cooking method changes the AGE content of food (illustrative, from Uribarri 2010)
FoodLower-AGE preparationHigher-AGE preparationWhy
Chicken breastPoached or stewedRoasted, fried or grilledDry heat browns protein and fat
BeefBraised or boiled (stew)Grilled or pan-friedSearing maximises the Maillard reaction
EggBoiled or poachedFried hardHigher pan temperature
PotatoBoiled or mashedChips, crisps, roastFrying and roasting brown the surface
VegetablesSteamed or rawRoasted with oilLow protein keeps AGEs modest either way

A useful, evidence-based trick from the same line of research: cooking with acid. Marinating meat in lemon juice or vinegar before grilling, or using a moist acidic sauce, measurably lowers new AGE formation because the lower pH slows the Maillard reaction.3 The practical message is not to ban roast dinners but to recognise that method, not just ingredient, sets the AGE load. This sits alongside the glucose side of the story we cover in glucose and continuous monitoring.

RAGE: how AGEs drive inflammation

If AGEs only stiffened proteins, they would be a slow mechanical problem. What makes them an active driver of disease is a receptor with an apt acronym: RAGE, the receptor for advanced glycation end-products. RAGE sits on the surface of many cell types, including the cells lining blood vessels and immune cells, and it binds AGEs (among other ligands). When an AGE engages RAGE, it sets off a signalling cascade inside the cell.4

The central event is activation of a master inflammatory switch called NF-kB. Once switched on, NF-kB turns up the production of inflammatory cytokines and adhesion molecules, and it increases the cell's output of reactive oxygen species, the molecules behind oxidative stress. Crucially, one of the genes NF-kB switches on is the gene for RAGE itself. So AGE binding makes a cell produce more RAGE, which lets it bind more AGEs, which drives more inflammation: a self-amplifying loop that converts a brief signal into sustained tissue stress.4

This RAGE-NF-kB axis is the mechanistic thread that ties AGEs to so many different conditions. Wherever there is chronic, low-grade inflammation in the blood vessels, the kidney filter, the joints or the ageing brain, AGE-RAGE signalling is plausibly part of the picture. It is worth being precise about the status of this knowledge: the receptor biology is well characterised in cells and animals, and it is the most convincing reason to take AGEs seriously, but it does not by itself prove that lowering your dietary AGEs will quiet that inflammation in humans. For the wider context of how chronic inflammation harms the body, see our overview of chronic inflammation.

The disease links: diabetes, skin, heart, kidney

Diabetic complications

The strongest disease case for AGEs is in diabetes, and it comes with an important twist. In the long-running DCCT/EDIC study of people with type 1 diabetes, the amount of AGE accumulated in skin collagen predicted the future progression of eye, nerve and kidney complications, and it did so independently of HbA1c. In other words, AGE burden carried risk information beyond average blood sugar. This is one proposed explanation for metabolic memory, the observation that a period of poor control can leave a lasting risk shadow even after sugar is brought down.5

Skin ageing

Skin is where AGEs are most visible. The dermis is built on collagen and elastin, both long-lived proteins, and when AGEs cross-link them the fibres become stiffer and lose their springy recoil. Glycated collagen also resists the enzymes that normally break down and recycle worn fibres, so damaged collagen lingers. The result, demonstrated in laboratory and observational work, is reduced elasticity, increased stiffness, a slightly yellowed tone and deeper wrinkles.8 This is genuine biology, though the leap from it to any specific anti-glycation cream working in humans is largely unproven and heavily marketed.

Heart and blood vessels

In the artery wall, AGE cross-linking of collagen contributes to the stiffening of large vessels, and AGE-RAGE signalling promotes the inflammation and oxidation that underlie atherosclerosis. Observational cohorts link higher AGE burden to cardiovascular events, but because high AGEs travel with diabetes, ageing and smoking, untangling cause from companion is difficult.9

Kidney disease

The kidney is doubly involved. It is both a target of AGE damage, contributing to the scarring of diabetic nephropathy, and the main route by which the body clears AGEs. As kidney function falls, AGEs are cleared less well and build up sharply: in people on dialysis, certain circulating AGE adducts are raised many-fold, which may then feed further vascular damage.7

How good is the evidence, honestly

This is the section the supplement adverts skip. The case for AGEs has three tiers of evidence, and it is important not to blur them.

Well established: the chemistry. AGEs form, they accumulate on long-lived proteins, they cross-link tissue, and they activate RAGE-driven inflammation in cells and animals. The endogenous link to high glucose is solid. None of this is in serious doubt.124

Reasonably supported but observational: the disease associations. Skin AGEs predict outcomes in diabetes and in the general population, and these are large, well-conducted cohorts.59 But association is not causation, and AGEs are entangled with the very things that cause the same diseases.

Genuinely uncertain: whether cutting dietary AGEs changes hard outcomes in people. Here two honest problems collide. First, a large fraction of ingested AGEs is never absorbed: studies estimate roughly 20 to 50% of eaten carboxymethyl-lysine is excreted, and most early Amadori products are broken down by gut bacteria before absorption.10 Second, the diet-restriction trials are small and short.

Evidence grade: strong for the underlying chemistry and the glucose link. Moderate but observational for AGEs predicting diabetic and cardiovascular outcomes. Weak and preliminary for the claim that restricting dietary AGEs improves long-term health, where the trials are few, small and short, and a large share of dietary AGEs is not even absorbed.

That said, the small trials are not nothing. The most-cited is a one-year randomised trial led by Helen Vlassara and colleagues, published in Diabetologia in 2016, in 138 adults over 50 with obesity and metabolic syndrome. Those assigned to a low-AGE diet, achieved purely by changing cooking method rather than what they ate, showed improved insulin resistance (HOMA-IR), lower inflammatory and oxidative markers, and a rise in protective defences such as SIRT1 and AGE-receptor-1, compared with the usual high-AGE diet.6 Several smaller trials in metabolic syndrome and prediabetes point the same way, toward better insulin sensitivity and lower inflammation, but the numbers are small and no trial has yet shown reduced heart attacks, strokes or deaths.6 Treat the diet story as promising and biologically reasonable, not proven. For how to think about evidence quality in general, see our insights.

Can you measure your own AGEs?

You can, indirectly. Because many AGEs fluoresce under ultraviolet light, a device called the AGE Reader shines UV onto the skin of the forearm and measures the glow that comes back, a technique called skin autofluorescence (SAF). It is quick, painless and needs no blood. SAF rises with age and is higher in people with diabetes, kidney disease and metabolic syndrome.9

Its predictive value is real. In the Dutch Lifelines cohort, skin autofluorescence in over 72,000 people without known diabetes or heart disease at baseline predicted who would go on to develop type 2 diabetes, cardiovascular disease and earlier death over the following years, even after accounting for traditional risk factors.9 The catch for an individual: SAF is mainly a research and risk-stratification tool, it is not a routine NHS test, readings vary between devices and with skin tone, and a single number does not tell you what to change. It is a barometer of accumulated metabolic stress, not a diagnosis.

What actually lowers your AGE burden

Given the evidence above, the sensible strategy is to focus first on the things with the firmest rationale, which means the glucose side as much as the food side. The interventions below are low-risk and align with general healthy-ageing advice, so they are reasonable even while the dietary-AGE trials remain preliminary.

What is not yet justified by good human evidence: spending money on "anti-AGE" or "anti-glycation" supplements and creams marketed on this mechanism. The biology is real, but proof that any specific product meaningfully lowers your AGE-related risk in a clinical sense is lacking. If you are weighing such products against better-evidenced options, our stack builder can help you keep priorities straight, and our start here guide is a better first step than any pill.

What to ask your GP
What to do next

References

  1. Khalid M, et al. 2022. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules. link
  2. Rhee SY, Kim YS. 2018. The Role of Advanced Glycation End Products in Diabetic Vascular Complications (and endogenous formation via methylglyoxal and the glyoxalase system). Diabetes & Metabolism Journal / Frontiers in Molecular Biosciences review. link
  3. Uribarri J, et al. 2010. Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic Association 110(6):911-916.e12. link
  4. Tobon-Velasco JC, et al. 2014. Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress. CNS & Neurological Disorders Drug Targets. link
  5. Monnier VM, et al. 2015. Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes (DCCT/EDIC). Diabetes 64(1):266-278. link
  6. Vlassara H, et al. 2016. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. Diabetologia 59:2181-2192. link
  7. Stinghen AE, et al. 2016. Uremic Toxicity of Advanced Glycation End Products in CKD. Journal of the American Society of Nephrology / Kidney International review. link
  8. Wang Z, et al. 2024. The effects of advanced glycation end-products on skin and potential anti-glycation strategies. Experimental Dermatology 33(4):e15065. link
  9. van Waateringe RP, et al. 2019. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population (Lifelines cohort). Diabetologia 62:269-280. link
  10. Nowotny K, et al. 2018. Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology. Nutrients 10(8):1133. link

This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.